Background-Endothelial senescence represents one of the major characteristics of vascular aging and promotes the development of atherosclerosis. Sirtuin-1 (SIRT1) is an NAD-dependent deacetylase possessing antiaging activities.
V ascular aging is a major risk factor for atherosclerosis and coronary artery disease. 1 In aged animals and elderly human subjects, the arterial endothelium exhibits morphological features of cellular senescence: flat and enlarged multinuclear endothelial cells that show positive staining of senescence-associated ␤-galactosidase (SA-␤-gal). [2] [3] [4] [5] [6] Cellular senescence correlates with aging-induced endothelial dysfunction and decreased production of endotheliumderived vasodilators such as nitric oxide and prostacyclin. [7] [8] [9] Moreover, senescent endothelial cells are proinflammatory and proatherosclerotic and have a decreased regenerative capacity. 10, 11 Multinucleated endothelial cells are almost invariably observed in atherosclerotic aortas and contribute to both the initiation and progression of atherosclerosis. 3, 12, 13 
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Sirtuin-1 (SIRT1), a mammalian ortholog of the yeast silent information regulator 2, is considered a longevity or aging regulator. 14, 15 SIRT1 is abundantly expressed in the vasculature and is crucially involved in postnatal vascular growth. 16 It promotes endothelial function and vasodilator responses by mediating NAD ϩ -dependent deacetylation of intracellular protein targets, including endothelial nitric oxide synthase, FoxO1, P53, LKB1, angiotensin II type 1 receptor, and P66Shc. 17 Reduced SIRT1 expression facilitates the occurrence of senescence in endothelial cells. 18 -20 In contrast, overexpression or activation of SIRT1 promotes endothelial function and suppresses vascular inflammation. [21] [22] [23] SIRT1 activity is regulated at the posttranslational level. 24 In addition, the function of SIRT1 is controlled by intracellular shuttling between different subcellular compartments. 25, 26 The results of the present study demonstrate that in senescent endothelial cells, SIRT1 is hyperphosphorylated at serine 47 (S47), which negatively affects its antisenescent and antiinflammatory functions by altering its intracellular localization and protein-protein interactions. Inhibition of cyclindependent kinase 5 (CDK5), a serine/threonine kinase responsible for SIRT1 phosphorylation, attenuates endothelial senescence and the development of atherosclerosis in mice.
Methods
All experimental procedures were approved by the Institutional Committee on the Use of Live Animals in Teaching and Research of the University of Hong Kong. More details are provided in the online-only Data Supplement.
Isolation and Culture of Primary Porcine Aortic Endothelial Cells
Primary porcine aortic endothelial cells (PAECs) were collected from hearts of female pigs (age, 3-4 months; weight, 25-30 kg) as described. 20 PAECs have a limited lifespan in culture and gradually become senescent. In the present study, a strict schedule was adopted for subculturing the cells at a fixed ratio once per week up to 4 weeks (designated P1-P4). Cell numbers were counted when seeding and harvesting from each passage for calculating population doubling (PDL): PDLϭ(log 10 FϪlog 10 I)/0.301, where F is the number of cells at the end of 1 passage and I is the number of cells that were seeded at the beginning of the passage. Native and regenerated endothelial cells were collected from pigs subjected to coronary angioplasty as described. [27] [28] [29] 
Animals and Drug Treatments
Apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). Endotheliumspecific human SIRT1 transgenic mice (ES-hSIRT1-TG or EShTG) in a C57BL/6J background were generated as described 20 and cross-bred with ApoE Ϫ/Ϫ mice for Ͼ10 generations to produce ApoE Ϫ/Ϫ EShTG mice for the present study. The animals were housed under controlled 12-hour light/dark cycle and temperature conditions, with free access to water and chow. To accelerate the development of atherosclerotic lesions, mice were fed a high-fat, high-cholesterol diet (D12079B, Research Diets, NJ). Roscovitine (2.5 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ) or resveratrol (20 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ) was administered by intraperitoneal injections. At the end of treatment, the mice were anesthetized with an intraperitoneal injection of a mixture of fluanisonum (25 mg/kg), fentanylum (0.78 mg/kg; Hypnorm, Janssen Pharmaceutica, Beerse, Belgium), and midazolam (12.5 mg/kg; Dormicum, Hoffman-La Roche, Basel, Switzerland). Loss of consciousness and suppression of reflexes (withdrawal reflex and tail-pinch response absent, limb muscle tone absent, regular heart and respiratory rates) were checked to ensure that the animal was anesthetized deeply enough.
Atherosclerosis Assessment
After removal of the adventitial fat, the thoracic aortas were cut longitudinally and pinned down for en face Oil Red O staining. In brief, the aortas were fixed in 60% isopropanol for 15 minutes, followed by incubation with freshly prepared 0.3% Oil Red O solution at room temperature for another 15 minutes. After rinsing in 60% isopropanol for 1 minute and twice in PBS, images of the aortas were captured with a digital camera, and the lesion area was analyzed with ImageJ software (National Institutes of Health, Bethesda, MD). In addition, the aortic root was collected from the base of the heart including the atria and embedded in optimal cutting temperature compound. Sections (5 m) were obtained every 50 m from the base of the aortic leaflets to 400 m above. After staining with Oil Red O, images were captured with a microscope, and the lesion area for each aortic ring was analyzed with ImageJ software.
Site-Directed Mutagenesis
The cDNA of human SIRT1 (NM_012238.4) was subcloned into a pCMV-3Tag-3 mammalian expression vector to produce a vector (Flag-hSIRT1-WT) encoding full-length human SIRT1 protein tagged with a COOH-terminal triple-Flag epitope. Site-directed mutagenesis was subsequently performed to generate 2 constructs in which the S47 was replaced by either alanine (Flag-hSIRT1-S47A) or aspartic acid (Flag-hSIRT1-S47D). Transient transfection was performed in PAECs with Effectene transfection reagent, and overexpression was confirmed by Western blotting using the anti-Flag antibody. In addition, vectors encoding glutathione S-transferase (GST)-tagged SIRT1 mutants (GST-hSIRT1-S47A and GST-hSIRT1-S47D) were constructed by use of the template plasmid GST-hSIRT1-WT. 30 All mutations were confirmed by DNA sequencing.
Protein Purification and Measurement of SIRT1 Activity
GST-tagged wild-type hSIRT1, S47A, or S47D mutant proteins were expressed in Escherichia coli DH5␣ strain transformed with GST-hSIRT1-WT, GST-hSIRT1-S47A, or GST-hSIRT1-S47D plasmid. GST-tagged recombinant proteins were purified by use of the GSTrap HP column (GE Healthcare Life Sciences, Uppsala, Sweden) according to the manufacturer's instruction. Flag-tagged wildtype hSIRT1, S47A, or S47D mutant proteins were purified from transiently transfected HEK293 cells. The deacetylase activity of 10 g of the purified recombinant protein was measured by an SIRT1 fluorometric drug discovery assay kit (Enzo Life Sciences International, Inc, Plymouth Meeting, PA) according to the manufacturer's instructions.
RNA Interference and Evaluation of Cellular Senescence
Three sets of porcine CDK5 siRNAs (RiboBio Co, Guangzhou, China) were used to suppress its mRNA expression in PAECs. In brief, 10 L of 20 mol/L siRNA mixture or scramble siRNA control was introduced into the cells with Lipofectamine 2000 transfection reagent. SA-␤-gal staining was performed with the Senescence Cells Histochemical Staining Kit (Sigma Aldrich, St. Louis, MO) according to the manufacturer's instruction.
Coimmunoprecipitation, In Vitro Phosphorylation, and Western Blot Analysis
PAECs were solubilized in radioimmunoprecipitation assay lysis buffer and incubated with anti-Flag M2 affinity agarose beads (Sigma Aldrich) at 4°C overnight on a shaking platform. After washing extensively with ice-cold PBS, the immunocomplexes were either used directly for in vitro phosphorylation assay or eluted with 0.1 mol/L glycine HCl (pH 3.0) and neutralized for SDS-PAGE and Western blotting analysis. In vitro phosphorylation was performed by coincubating 10 g of recombinant proteins with 250 ng of CDK5/P25 complex (Life Technologies, Grand Island, NY) in 25 L kinase assay buffer (50 mmol/L HEPES, pH 7.5, 10 mmol/L MgCl 2 , 1 mmol/L EGTA, 1 mmol/L phenylmethanesulfonyl fluoride, 0.01% Brij-35, 1 mmol/L dithiothreitol, 1 mmol/L Na 3 VO 4, 1 mmol/L NaF, 1ϫ protease inhibitor cocktail, 2.5 Ci of [␥-32 P] ATP, and 100 mol/L unlabeled ATP) for 1 hour at 30°C. Reactions were stopped by the addition of SDS-PAGE loading buffer and boiling for 5 minutes. Samples were then separated by SDS-PAGE, and radioactive signaling was detected by autoradiography.
Immunofluorescence Analysis
Cells cultured on coverslips were fixed with cold methanol/acetone (1:1 vol/vol) for 15 minutes and then permeabilized with 1% Triton X-100 in PBS for 5 minutes. After blocking with 3% BSA for 1 hour, cells were incubated with specific primary antibody at 4°C overnight. After washing with PBS, cells were then incubated with Alexa Fluor 594 -labeled secondary antibodies (Invitrogen, Carlsbad, CA) at dilutions of 1:500 for 1 hour at room temperature in the dark. The slides were mounted with ProLong Gold antifade reagent with DAPI (Invitrogen). Fluorescent images were taken with a BX-41 microscope (Olympus, Tokyo, Japan).
Evaluation of CDK5 Activity in PAECs
CDK5 complexes were immunoprecipitated from PAECs or tissue lysates and incubated with histone H1 in kinase assay buffer for 1 hour at 30°C. Reactions were stopped by the addition of SDS-PAGE protein loading buffer and boiling for 5 minutes. The phosphorylation levels of histone H1 were monitored as an indicator of CDK5 activity. 31
Data Analysis
For cellular senescence analysis, images were taken from at least 10 random fields, and cells with positive SA-␤-gal staining were counted manually and expressed as the percentage of the total number of cells. The density of protein bands in Western blots was measured for calculating the expression ratios against ␤-actin loading control. All studies were repeated at least 3 times. Results were presented as meanϮSEM. Statistical analysis of differences between Ն2 groups was performed by use of an unpaired t test or ANOVA. Atherosclerotic lesion area was analyzed by ANOVA and the post hoc Tukey test. Values of PϽ0.05 were accepted to indicate statistically significant differences.
Results

Endothelial Senescence Is Associated With Increased Phosphorylation of SIRT1 at S47
The progression to cellular senescence during the prolonged culture of PAECs has been reported. 20, 27, 28 The growth rate of PAECs was reduced progressively from P1 (PDL, 4.35) to P4 (PDL, 0.025). During 1 month of culture, the portion of senescent cells progressively increased from 6.58% (P1) to 45.55% (P2) to 67.32% (P3) to 90.73% (P4) as analyzed by flow cytometry. 20 At a cumulative PDL of 10.28, almost 100% of the PAECs were positive for SA-␤-gal staining (data not shown). Western blotting was performed to compare the phosphorylation of SIRT1 in young and old cells using an antibody against phosphoserine/threonine ( Figure I in the online-only Data Supplement). Phosphorylation of SIRT1 was significantly elevated in senescent PAECs. A commercially available antibody specifically recognizing the phosphorylation at S47 of SIRT1 was subsequently used for evaluation in cells collected at 1, 2, 3, and 4 weeks of passages after initial seeding ( Figure 1A , left). Although the phosphorylation was barely detectable in young (P1) PAECs, it gradually increased during the development of cellular senescence. In P4 cells, the ratio of phosphorylated SIRT1 (p-SIRT1) to total SIRT1 (t-SIRT1) was augmented Ͼ9-fold compared with that in P1 cells. The p-SIRT1 levels in regenerated endothelial cells collected from porcine aortas 4 weeks after balloon denudation injury 29 were also elevated compared with native cells (Figure 1A , right). The association of p-SIRT1 with cellular senescence was further confirmed in PAECs treated with hypercholesterolemic serum collected from ApoE Ϫ/Ϫ mice, H 2 O 2 , or low-density lipoprotein cholesterol ( Figure 1B and 1C) . In contrast, resveratrol or high-density lipoprotein cholesterol treatment decreased senescence and p-SIRT1 levels in PAECs ( Figure 1C ). Overexpression of LKB1, a serine/threonine protein kinase, or its downstream target, AMP-activated protein kinase (AMPK), in PAECs promotes senescence. 20 The present results revealed that activation of both LKB1 and AMPK significantly stimulated SIRT1 phosphorylation at S47 ( Figure 1D ).
Next, 3 mammalian expression vectors encoding wild-type human SIRT1 (hSIRT1), mutant S47A, and mutant S47D were constructed and used for transient transfection in PAECs. Compared with cells transfected with pcDNA vector, the number of senescent cells was reduced significantly in PAECs overexpressing hSIRT1 (by Ϸ42%) or S47A (by Ϸ56%; Figure 2A ), and the proliferation was enhanced significantly by augmenting either of these 2 proteins ( Figure  2B ). The antisenescence and growth-promoting activity of SIRT1 was improved further by substitution of S47 to alanine (S47A; mimicking a nonphosphorylated form) but lost upon mutation of this residue to a phosphor mimetic aspartic acid (S47D). The deacetylase activity was evaluated for the 3 versions of SIRT1 proteins purified from E coli. Compared with hSIRT1 and S47A, S47D exhibited a significantly decreased basal and stimulated (by S17834, SRT1720, or resveratrol) enzymatic activity ( Figure II in the online-only Data Supplement). In PAECs transfected with Flag-hSIRT1-WT or Flag-hSIRT1-A47 expression vectors, the level of acetylated histone H4 was significantly lower than in cells transfected with pcDNA ( Figure 2B ). LKB1, the intracellular protein target of SIRT1, 20, 32 was downregulated by hSIRT1 and to a greater extent by S47A ( Figure 2D ), whereas S47D did not affect LKB1 protein expression levels. The protein-protein interaction between endogenous LKB1 and S47A was the strongest among the 3 versions of SIRT1. S47D mutation significantly attenuated the protein binding with LKB1 ( Figure 2D ).
Phosphorylation of SIRT1 at S47 Is Mediated by CDK5
The NetPhosK 1.0 (http://www.cbs.dtu.dk/services/NetPhosK) program predicted that CDK5 and glycogen synthase kinase 3 were potential upstream kinases responsible for phosphorylation at S47. To verify this in silico prediction, pharmacological inhibitors (roscovitine, a CDK5 inhibitor; LY294002, a PI3K inhibitor; lithium chloride, a glycogen synthase kinase 3 inhibitor; and SP600125, a c-Jun N-terminal kinase inhibitor) were used to treat PAECs. Roscovitine, but not the other inhibitors, significantly reduced (by Ͼ70%) the phosphorylation of SIRT1 at S47 ( Figure 3A ). Roscovitine also concentration-dependently reduced the amount of acetylated H4 in PAECs ( Figure III in the online-only Data Supplement). The siRNA knockdown of CDK5 had an inhibitory effect on S47 phosphorylation similar to that of roscovitine ( Figure 3B , left). PAEC cultures with lower expression levels of CDK5 or decreased CDK5 activity contained significantly reduced numbers of senescent cells ( Figure 3B, right) . Treatment with roscovitine also inhibited phosphorylation of SIRT1 induced by constitutively active AMPK ( Figure 3C ), indicating that AMPK indirectly enhanced CDK5-mediated SIRT1 phosphorylation.
Direct protein-protein interaction between SIRT1 and endogenous CDK5 was confirmed by coimmunoprecipitation. Using the M2 anti-Flag agarose beads, CDK5 was detected in the immunocomplexes precipitated from PAECs transiently transfected with Flag-hSIRT1-WT but not pcDNA vector ( Figure 4A ). The in vitro phosphorylation assay further validated the ability of CDK5 complexes to phosphorylate SIRT1 at S47 ( Figure 4B and 4C). The phosphorylation of Flag-tagged hSIRT1 was enhanced significantly by incubation with either immunoprecipitated CDK5 protein complex obtained from mammalian cell cultures or commercial CDK5/P25 active complex ( Figure 4B ). The weak radioactive phosphorylation signal under basal conditions could be due to residual contamination of SIRT1 upstream kinases, including CDK5. The enhanced phosphorylation at S47 was verified by Western blotting. In addition, an in vitro phosphorylation assay was performed using purified GST-tagged wild-type hSIRT1, which should not contain any phosphorylated resi- A, Cellular lysates derived from P1 through P4 (left) or native/regenerated (right) primary cultures of PAECs were subjected to Western blotting to measure total (t) and phosphorylated (p) SIRT1 levels. B, PAECs (P2) were incubated for 24 hours in Dulbecco modified Eagle medium (DMEM) containing 5% serum derived from C57BL/6J or apolipoprotein E-deficient mice or treated for 1 hour with 100 mol/L H 2 O 2 and then cultured in DMEM with 10% FBS for another 72 hours. Senescence-associated ␤-galactosidase (SA-␤-gal) staining was performed at the end of treatment, and the positively stained cells were counted manually. The p-SIRT1 and t-SIRT1 were detected by Western blotting using the collected cell lysates. C, Cellular senescence and SIRT1 phosphorylation were monitored in PAECs (P2) incubated in DMEM containing high-density lipoprotein (HDL; 50 mg/L), low-density lipoprotein (LDL; 50 mg/L), or resveratrol (100 mol/L) for 24 hours. D, Left, PAECs (P3) were treated with AMP-activated protein kinase (AMPK) activator (AICAR; 24 hours) or inhibitor (compound C; 24 hours) or infected with recombinant adenovirus (constitutively active [CA]-AMPK) or dominant-negative AMPK (DN-AMPK). Right, PAECs (P3) were transfected with pcDNA or expression vector for Flag-tagged LKB1. 20 LKB1 overexpression and activation were confirmed by probing with antibodies against the Flag peptide, phosphorylated AMPK (p-AMPK), and acetyl CoA carboxylase (p-ACC). The t-SIRT1 and p-SIRT1 levels were measured by Western blotting, and ratios were calculated as described in Methods. All Western blotting results were presented as fold changes of p-SIRT1/t-SIRT1 ratios against the respective control groups. Senescence status was expressed as the percentage of PAECs positively stained for SA-␤-gal. *PϽ0.05 vs corresponding control groups; nϭ4 to 5.
dues before coincubation with CDK5 complexes ( Figure 4C ). Both the CDK5 immunoprecipitates and the commercial CDK5/P25 complex promoted the phosphorylation of hSIRT1, and this was attenuated significantly by roscovitine. Although GST-tagged S47A could also be phosphorylated by the CDK5/P25 complex, the intensity was significantly lower than that of the wild-type hSIRT1 protein ( Figure 4C ).
Phosphorylation at S47 Prevents Nuclear Exportation of SIRT1 and the Interaction With Telomeric Repeat-Binding Factor 2-Interacting Protein 1
In young PAECs, endogenous SIRT1 was distributed in both cytoplasm and nucleus, including nucleolus ( Figure 5A ). In old PAECs, however, SIRT1 accumulated mainly in the nucleus, and the intensity decreased significantly. The p-SIRT1 was located in the nucleus of both young and old PAECs (Figure 5A, left) . Unlike t-SIRT1, p-SIRT1 was not concentrated in the nucleolus but was distributed widely in the nucleus. Western blotting confirmed the augmented amount of p-SIRT1 in nuclear fractions of P4 cells ( Figure   5A , right). In transfected PAECs, S47D mutant accumulated exclusively in the nucleus, whereas the S47A mutant was detected predominantly in the cytoplasm. S47D showed a nuclear localization similar to that of p-SIRT1 ( Figure 5B , left). Roscovitine promoted the translocation of hSIRT1 to the cytoplasm, and this effect was abolished by leptomycin B, a nuclear exportation inhibitor. 33 The cytoplasm translocation of S47A was also blocked by leptomycin B (Figure 5B , right), suggesting that S47 phosphorylation prevented nuclear-cytoplasmic shuttling of SIRT1.
Telomeric repeat-binding factor 2-interacting protein 1 (TERF2IP) is a regulator of telomere function and acts as a critical regulator of nuclear factor-B signaling. 34 Immunoprecipitation revealed that both endogenous SIRT1 and IB␣ interacted with TERF2IP ( Figure 5C ). Although exogenous hSIRT1 was present in the immunocomplex of TERF2IP, S47D did not bind with TERF2IP despite its nuclear location ( Figure 5C, left) . In young PAECs, TERF2IP accumulated in the nucleolus and was distributed in the cytoplasm. In senescent PAECs, the cytoplasmic protein amount of TERF2IP was elevated significantly (Figure 5C, right) . Com- pared with P1 cells, the expression of cyclooxygenase-2 (COX2), a downstream gene regulated by nuclear factor-B, increased significantly in P4 cells ( Figure 5D, left) . Moreover, the gene expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, monocyte chemoattractant protein-1, and E-selectin was elevated up to 60-fold ( Figure IV in the online-only Data Supplement). In old PAECs, overexpression of hSIRT1 reduced COX2 expression, whereas S47D showed little effects ( Figure 5D , left). The inflammatory cytokine tumor necrosis factor-␣ significantly induced the expression of COX2 and the phosphorylation of SIRT1. The phosphorylation of IB␣ was promoted by tumor necrosis factor-␣, and this effect was blocked by roscovitine ( Figure 5D, right) . Tumor necrosis factor-␣-stimulated expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, monocyte chemoattractant protein-1, and E-selectin was also blocked by roscovitine ( Figure IV in the online-only Data Supplement). The results revealed that phosphorylation at S47 abolished the nuclear-cytoplasmic shuttling of SIRT1 and the antiinflammatory activity of this protein.
Inhibition of CDK5 Blocks the Development of Atherosclerosis in ApoE ؊/؊ Mice
To confirm the role of CDK5 in endothelial senescence, the activity of this kinase was examined by the use of cell lysates derived from young and old PAECs. In P4 cells, the CDK5 activity, as evaluated by histone H1 phosphorylation, was significantly augmented compared with P1 cells ( Figure 6A ). However, the total protein content of CDK5 was not altered ( Figure 6B ). In senescent P4 PAECs, the protein levels of P25, a truncated regulatory subunit of CDK5, were signifi- cantly elevated Ͼ5-fold ( Figure 6B, top) . An augmented P25 content was consistently observed in PAECs treated with hypercholesterolemic serum derived from ApoE Ϫ/Ϫ mice (Figure 6B, bottom) . On the other hand, resveratrol treatment reduced the protein amount of P25 ( Figure V in the onlineonly Data Supplement). Overexpression of CDK5, P25, or CDK5 plus P25 increasingly stimulated SIRT1 phosphorylation at S47 and elevated the total LKB1 level ( Figure 6C) . In contrast, the phosphorylation of SIRT1 at S47 and LKB1 protein expression were reduced significantly by the overexpression of dominant-negative CDK5 (Figure 5C, right) . These results were in line with the negative regulatory effects of SIRT1 on LKB1 protein stability. 20 In PAECs, only a small amount of CDK5 was bound to P25, whereas most of the latter was associated with CDK5 ( Figure 5C, bottom) . This partly explained the incremental effects of CDK5, P25, or their combination on SIRT1 phosphorylation, LKB1 protein expression, and cellular senescence ( Figure VI in the onlineonly Data Supplement).
In ApoE Ϫ/Ϫ mice fed a high-fat, high-cholesterol diet, the occurrence of atherosclerosis in the aorta was closely associated with the development of cellular senescence ( Figure  VII in the online-only Data Supplement). Moreover, the total amount of SIRT1 decreased progressively in the aortic tissues, whereas the protein expression of COX2 increased. Both the kinase activity of CDK5 and the protein levels of P25 were increased significantly in aortic tissues of ApoE Ϫ/Ϫ mice compared with age-matched controls ( Figure VIII in the online-only Data Supplement). To further validate the physiological relevance of CDK5 activation in atherosclerosis, roscovitine was administered long term to ApoE Ϫ/Ϫ mice, starting at the age of 4 weeks when they were exposed to the Western diet. After 18 weeks of daily intraperitoneal injection of roscovitine, the aortas were collected for SA-␤-gal staining and atherosclerosis evaluation. Long-term administration with the CDK5 inhibitor significantly reduced the atherosclerotic lesions and the SA-␤-gal-positive areas of the descending aortas to greater extent than observed in resveratroltreated mice ( Figure 7A and 7B) . The gene expression of COX2, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, monocyte chemoattractant protein-1, and E-selectin was significantly downregulated by treatment with roscovitine ( Figure 7C ). The average area of lipid-stained lesions throughout the aortic root was also significantly reduced by roscovitine ( Figure 7D ). Similar antisenescent and antiatherosclerotic effects of roscovitine were observed in ApoE Ϫ/Ϫ EShTG mice ( Figure IX in the online-only Data Supplement). In these mice, the p-SIRT1 level and the amount of P25 protein in aortic tissues were progressively augmented ( Figure IXA in the online-only Data Supplement). A significant reduction of t-SIRT1 was observed after 25 weeks of Western diet. Roscovitine treatment did not change the protein amount of Flag-tagged hSIRT1 but decreased those of p-SIRT1 and COX2 ( Figure XIB in the online-only Data Supplement).
Discussion
SIRT1 elicits vasoprotective activity by promoting angiogenesis, preventing endothelial senescence, enhancing vasodilatation, and inhibiting inflammation. 17, 19, 35 Decreased SIRT1 expression and activity are associated with the progression of endothelial senescence and dysfunction. 18, 20, 36 In fact, reduced SIRT1 function has been implicated in other agingassociated diseases, including neurodegeneration, cancer, inflammation, obesity, and metabolic disorders. 15 However, the mechanisms underlying the loss-of-SIRT1 activity are largely unknown.
Posttranslational modifications such as sumoylation, alkylation, and phosphorylation play a role in regulating SIRT1 function. 24 For example, casein kinase 2-mediated phosphor- . Cyclin-dependent kinase 5 (CDK5) acts as the upstream kinase to phosphorylate (p) sirtuin-1 (SIRT1) at serine 47 (S47). A, Immunoprecipitation (IP) was performed to precipitate Flag-tagged hSIRT1 from porcine aortic endothelial cells transfected with Flag-SIRT1-WT. The presence of CDK5 in the immunocomplexes was confirmed by Western blotting (WB) using its specific antibody. B, In vitro phosphorylation assay was performed by coincubating Flag-tagged hSIRT1 with either immunoprecipitated CDK5 protein complex (left) or commercial CDK5/P25 active complex. Increased phosphorylation was confirmed by Western blotting. C, In vitro phosphorylation assay was performed as above with GST-tagged hSIRT1 or GST-tagged S47A protein purified from Escherichia coli. Both immunoprecipitated CDK5 protein complex (left) and commercial CDK5/P25 active complex were used for the assays. Note that the phosphorylation was largely inhibited by coincubating with roscovitine. CBB indicates Coomassie Brilliant Blue.
ylation at the COOH-domain of SIRT1 increases its deacetylase activity and substrate-binding affinity, in turn promoting the antiapoptotic function of the protein. 37 ,38 SIRT1 can be phosphorylated by cyclin B/Cdk1, also at the COOH-terminal region. 39 Unlike these earlier reports suggesting that loss of SIRT1 phosphorylation leads to a decline in its deacetylase activity, the present study demonstrates that in endothelial cells, phosphorylation of SIRT1 at S47 exerts an inhibitory effect on its biological functions. During the progression of cellular senescence, although the total SIRT1 protein level is Figure 5 . Phosphorylation (p) of sirtuin-1 (SIRT1) at serine 47 (S47) affects its subcellular localization and protein-protein interactions. A, Left, porcine aortic endothelial cells (PAECs) at P1 and P4 were subjected to immunofluorescent staining with antibodies against total (t) SIRT1 or p-SRIT1 (S47). Magnification ϫ400. Right, The p-SIRT1 levels were measured by Western blotting using the nuclear fractions collected from P1 and P4 cells. cAMP response element-binding (CREB) and ␤-actin were probed as nuclear and cytoplasmic markers, respectively. B, Left, Immunofluorescent staining was performed in PAECs (P3) transiently overexpressing hSIRT1, S47A, or S47D using the specific antibody recognizing the Flag epitope. Right, The cellular localization of Flag-tagged proteins was monitored in transiently transfected cells treated with roscovitine (10 mol/L, 12 hours), leptomycin B (LMB; 10 nmol/L, 3 hours), or both. Magnification ϫ400. C, Left, immunoprecipitation was performed in nontransfected or transiently transfected PAECs (P2) using antibody recognizing telomeric repeat-binding factor 2-interacting protein 1 (TERF2IP). Right, Intracellular localization of TERF2IP was monitored by immunofluorescent staining in P1 and P4 cells. Magnification ϫ1000. The cytoplasmic protein amount of TERF2IP was quantified by Western blotting. D, Left, Protein expression of cyclooxygenase-2 (COX2) was measured in nontransfected or transiently transfected PAECs. Right, PAECs (P2) were incubated with tumor necrosis factor-␣ (TNF␣; 10 ng/mL, 6 hours) in the presence or absence of roscovitine (10 mol/L, 12 hours). The protein expression of COX2, p-and t-IB␣, and p-and t-SIRT1 was monitored by Western blotting. reduced, the relative phosphorylation at S47 increases. Mutation of this single amino acid residue to the phosphomimetic form S47D abolishes the antisenescence and antiinflammatory activity of SIRT1, whereas replacing the serine residue with nonphosphorable alanine enhances the antisenescence and growth-promoting effects of this protein.
Within the NH 2 -terminal region of hSIRT1, there are 2 functional nuclear localization sequences (NLS1, aa32-38; NLS2, aa232-238) and 1 nuclear export signal (NES, aa146 -153). 25 S47 is in close proximity to NLS1 and predicted to be part of a nucleolar localization sequence (http://www.compbio. dundee.ac.uk/www-nod/; Figure 8A ). Thus, phosphorylation at this site may modify the coordination of these localization signals (Figure 8 ). Apparently, phosphorylated and nonphosphorylated SIRT1 is located within different cellular compartments. Hyperphosphorylated SIRT1 is accumulated mainly in the nucleus and shows a distinctive pattern of intranuclear localization: reduced accumulation in nucleoli and absence around the nuclear membrane but enhanced granular distribution in the nucleoplasm. The nonphosphor-able mutant (S47A) and nonphosphorylated wild-type SIRT1 are found around the nuclear rim and are widely dispersed throughout the cytoplasm. In addition, a portion of the wild-type nonphosphorylated SIRT1 accumulates within nucleoli. These results demonstrate that phosphorylation at S47 plays an active role in determining the dynamic localization of SIRT1 ( Figure 8B ). Preventing this phosphorylation, eg, by CDK5 inhibition, facilitates the translocation of SIRT1 to the cytoplasm and the interaction with LKB1, a senescencepromoting kinase located mainly in cytosolic compartment (data not shown). The enhanced binding of nonphosphorylated SIRT1 to LKB1 facilitates the degradation of this kinase. 20 In young PAECs, both nonphosphorylated SIRT1 and TERF2IP colocalize within the nucleolus. However, in old PAECs, hyperphosphorylation of SIRT1 abolishes the interactions between the two proteins, in turn causing elevated cytoplasmic accumulation of TERF2IP and the induction of nuclear factor-B signaling. Thus, the regulation of S47 phosphorylation not only determines the subcellular localization of SIRT1 but also governs its interactions with specific protein Figure 6 . Intracellular accumulation of P25 causes hyperactivation of cyclindependent kinase 5 (CDK5) in porcine aortic endothelial cells (PAECs). A, Cell lysates were collected from P1 and P4 cells for evaluation of CDK5 activity using histone H1 as the substrate. After SDS-PAGE, the amount of phosphorylated H1 was monitored by Western blotting and presented as the ratio to total histone H1. B, The protein levels of P25 and CDK5 were measured in young P1 and senescent P4 cells (top) and in PAECs (P3) cultured in the presence of serum (5%) derived from C57 or apolipoprotein E-deficient mice. C, Transient transfection was performed in PAECs (P3) for overexpressing CDK5 (HA-CDK5), P25 (P25C-GFP), or both (CDK5/ P25). Dominant-negative (DN) CDK5 was also included for overexpressing the DN-CDK5. After confirmation of the expression of exogenous CDK5 or P25, phosphorylation of sirtuin-1 (SIRT1) at serine 47 and LKB1 protein expression was evaluated by Western blotting. The interaction between CDK5 and P25 in PAECs was evaluated by coimmunoprecipitation with nonspecific IgG, anti-CDK5, or anti-P25, respectively. *PϽ0.05 vs corresponding control group; nϭ3 to 5. targets. Hyperphosphorylation of SIRT1 at S47 disrupts the interactions with cytosolic LKB1 and nucleolar TERF2IP ( Figure 8B ).
Phosphorylation at S47 of SIRT1 has been reported by a number of studies in various human carcinoma cells. The phosphorylation is associated with the induction of premature senescence in A431 cells and can be cross-regulated by mammalian target of rapamycin signaling pathway. 40 In colon cancer cells, c-Jun N-terminal kinase-2 (JNK2), but not JNK1, is positively associated with the occurrence of S47 phosphorylation. 41 In HEK293 cells, oxidative stress promotes the interactions between SIRT1 and JNK1, but an in vitro phosphorylation assay suggests that JNK1 stimulates phosphorylation of truncated human SIRT1 that lacks the region containing S47. 42 Results from the present study do not support JNK1 as the upstream kinase responsible for SIRT1 S47 phosphorylation in PAECs. Although no direct evidence is available suggesting that JNK1 phosphorylates human or porcine SIRT1 at S47, it may promote the phosphorylation of the S46 residue in murine SIRT1. 42 The amino acid sequences immediately after the S47-containing CDK5 motif of human SIRT1 (GGAAPER) share high homology with those of porcine SIRT1 (GGAALER) but differ significantly from those of murine SIRT1 (PSAAVAP), which may explain why the antibody for phosphorylated SIRT1 S47 could not provide positive signals in various murine tissues.
CDK5 is a serine/threonine kinase that has been implicated in neurodegeneration. 43 It also promotes muscle cell differentiation by enhancing the expression of myogenic differentiation antigen and myogenic regulatory factor, key regulators of myogenesis. 44 In pancreatic ␤ cells, inhibition of CDK5 enhances glucose-induced insulin secretion. 45 CDK5 is activated during premature cellular senescence induced by oncogenes. 46 In primary human endothelial cells, roscovitine prevents endothelial activation and blocks leukocyte-endothelial cell interactions. 47 The present results demonstrate that CDK5 plays a key role in regulating SIRT1 phosphorylation during the development of endothelial senescence. The elevated activity of CDK5 was confirmed in senescent endothelial cells and aortic tissues from hypercholesterolemic ApoE Ϫ/Ϫ mice. Inhibition of CDK5 by multiple approaches, including treatment with pharmacological inhibitors, overexpression of a dominant-negative mutant of CDK5, or silencing via RNAi, attenuated SIRT1 S47 phosphorylation and blocked cellular senescence. Although other serine residues of SIRT1 could potentially be phosphorylated by CDK5, the present study focused mainly on S47 because its specific antibody is available. Long-term treatment with roscovitine, at a concentration lower than other studies, 48, 49 blocked the development of senescence and atherosclerosis in aortic tissues of ApoE Ϫ/Ϫ mice. The primary determinant of the CDK5 activity is the amount of its activator, P35, which is short-lived and cleaved to P25 by calpain. Arterial remodeling and aging are associated with increased activity of calpain. 50 In the present study, elevated P25 protein expression was observed in both senescent PAECs and atherosclerotic aortas. Moreover, overexpression of P25 or P25 plus CDK5 promoted SIRT1 S47 phosphorylation and endothelial senescence to a greater extent than the actions of CDK5 alone, suggesting that the abnormal intracellular accumulation of P25 plays a critical role in causing Figure 7 . Long-term treatment with roscovitine attenuates the development of atherosclerosis in apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) mice. Vehicle, roscovitine, or resveratrol was administered daily to ApoE Ϫ/Ϫ mice fed a high-fat, high-cholesterol diet from the age of 4 weeks. After 18 weeks of treatment, Oil Red O (A) and senescence-associated ␤-galactosidase (SA-␤-gal) (B) staining was performed using aortas collected from all groups of mice. The gross lesion area was quantified as described in Methods and is presented as chart bars. The inflammatory gene expression in aortas tissues was evaluated by quantitative polymerase chain reaction (C). In addition, microscopic lesions were monitored and quantified using tissue sections prepared from aortic roots (D). Magnification ϫ40. ICAM-1 indicates intercellular adhesion molecule-1; VCAM-1, vascular cell adhesion molecule-1; MCP-1, monocyte chemoattractant protein-1; and SELE, and E-selectin. *PϽ0.05 vs vehicle control group; nϭ8. SIRT1; A) and the dynamic distribution of nonphosphorylated and phosphorylated SIRT1 in young or old porcine aortic endothelial cells (PAECs; B) . Note that phosphorylation abolished the interactions of SIRT1 with LKB1 in cytosol and telomeric repeat-binding factor 2-interacting protein 1 (TERF2IP) in nucleolus. The increased cytoplasmic translocation of TERF2IP promotes inflammatory nuclear factor-B (NF-B) signaling in old PAECs.
